Viewing Study NCT04355793


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-06-25 @ 1:23 AM
Study NCT ID: NCT04355793
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2021-12-15
First Post: 2020-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection
Sponsor: Incyte Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SARS-CoV-2 View
None Cytokine Storm View
None ruxolitinib View